GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (WBO:MRCK) » Definitions » Total Long-Term Liabilities

Merck KGaA (WBO:MRCK) Total Long-Term Liabilities : €13,041 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Merck KGaA Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Merck KGaA's Total Long-Term Liabilities for the quarter that ended in Dec. 2023 was €13,041 Mil.

Merck KGaA Total Long-Term Liabilities Historical Data

The historical data trend for Merck KGaA's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Total Long-Term Liabilities Chart

Merck KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14,052.00 15,548.00 13,514.00 13,016.00 13,041.00

Merck KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13,016.00 12,851.00 13,164.00 12,926.00 13,041.00

Merck KGaA Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Merck KGaA Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck KGaA (WBO:MRCK) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (WBO:MRCK) » Definitions » Total Long-Term Liabilities
Comparable Companies
XTER:EVT ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX HKSE:03692 TSE:4507 NSE:DIVISLAB BOM:500124 BOM:532321 BOM:543904 TSE:4523 NSE:TORNTPHARM CTLT XPAR:IPN
Traded in Other Exchanges
MKKGY:USA MKGAF:USA MRK:Italy MRKd:UK 0O14:UK MRK:Germany
Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Website
https://www.emdgroup.com
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA (WBO:MRCK) Headlines

No Headlines